Edition:
United States

Myriad Genetics Inc (MYGN.OQ)

MYGN.OQ on NASDAQ Stock Exchange Global Select Market

43.71USD
20 Jul 2018
Change (% chg)

-- (--)
Prev Close
$43.71
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
279,390
52-wk High
$44.31
52-wk Low
$23.34

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 193.50 0.157
Dec 194.00 -0.007
Sep 190.20 1.152
FY 2017 Jun '17 200.50 0.184
Mar '17 196.90 0.061
Dec 196.50 0.086
Sep 177.50 -0.017
FY 2016 Jun '16 186.40 0.482
Mar '16 190.50 0.469
Dec 193.30 0.503
Sep 183.50 0.420
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 10 188.22 192.33 187.00 --
Quarter Ending Jun-18 11 195.76 200.00 194.00 198.91
Year Ending Jun-18 14 773.84 780.35 771.90 789.07
Year Ending Jun-19 10 803.92 970.07 745.00 809.96
Earnings (per share)
Quarter Ending Mar-18 13 0.27 0.28 0.26 --
Quarter Ending Jun-18 13 0.33 0.35 0.32 0.27
Year Ending Jun-18 14 1.21 1.22 1.19 1.08
Year Ending Jun-19 10 1.40 1.50 1.33 1.12
LT Growth Rate (%) 2 16.85 17.00 16.70 -13.46
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 29.41 37.52 33.34
P/E High - Last 5 Yrs. 81.55 78.99 47.12
P/E Low - Last 5 Yrs. 15.22 22.83 24.95
Beta 0.48 0.87 0.81
Price to Sales (TTM) 3.93 18.73 8.11
Price to Book (MRQ) 3.22 5.26 4.23
Price to Tangible Book (MRQ) 19.02 5.37 6.21
Price to Cash Flow (TTM) 19.47 28.95 22.22
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.65 1.72
Dividend Yield - 5 Year Avg -- 0.68 1.46
Dividend 5 Year Growth Rate -- 5.02 -6.39
Payout Ratio(TTM) 0.00 20.05 47.39

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -1.73 7.78 4.76
Sales (TTM) vs TTM 1 Yr. Ago 2.76 9.07 12.32
Sales - 5 Yr. Growth Rate 9.23 5.33 7.68
EPS (MRQ) vs Qtr. 1 Yr. Ago 156.07 68.88 48.99
EPS (TTM) vs TTM 1 Yr. Ago 142.49 -- --
EPS - 5 Yr. Growth Rate -24.56 17.86 7.97
Capital Spending - 5 Yr. Growth Rate -9.87 10.99 7.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 3.16 1.74 2.56
Current Ratio (MRQ) 3.52 2.21 3.63
LT Debt to Equity (MRQ) 7.31 31.66 13.08
Total Debt to Equity (MRQ) 7.31 41.43 17.18
Interest Coverage (TTM) 18.86 37.27 35.06

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 77.63 47.90 55.23
Gross Margin - 5 Yr. Avg. 81.74 55.96 53.18
EBITD Margin (TTM) 22.92 -- --
EBITD - 5 Yr. Avg 26.80 12.62 15.61
Operating Margin (TTM) 16.17 -12.84 -0.70
Operating Margin - 5 Yr. Avg. 23.43 4.48 10.75
Pre-Tax Margin (TTM) 16.14 -13.08 1.18
Pre-Tax Margin - 5 Yr. Avg. 23.57 2.70 10.87
Net Profit Margin (TTM) 13.43 -15.63 -2.12
Net Profit Margin - 5 Yr. Avg. 15.12 0.50 7.23
Effective Tax Rate (TTM) 16.80 22.34 20.83
Effective Tax Rate - 5 Yr. Avg. 35.83 22.24 24.29

Efficiency

  Company industry sector
Revenue/Employee (TTM) 324,250 17,455,384 740,084,415
Net Income/Employee (TTM) 43,542 1,253,353 86,307,671
Receivable Turnover (TTM) 6.53 4.67 5.95
Inventory Turnover (TTM) 4.31 4.65 3.69
Asset Turnover (TTM) 0.63 0.72 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 8.41 2.03 10.36
Return on Assets - 5 Yr. Avg. 13.01 5.44 11.03
Return on Investment (TTM) 9.63 8.76 13.18
Return on Investment - 5 Yr. Avg. 14.43 6.80 14.26
Return on Equity (TTM) 12.35 12.58 15.09
Return on Equity - 5 Yr. Avg. 15.45 8.10 15.57
  1 Year 3 Year 5 Year
Sales % 2.33 -0.29 9.23
EPS (TTM) % -81.44 -48.00 -24.56
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Myriad Genetics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 12.45 10.57 99 93
13 Week 51.25 44.14 99 96
26 Week 13.18 13.52 99 97
52 Week 79.73 58.66 99 77
YTD 27.27 21.44 99 95
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 356
Total Shares Held: 74,961,140
3 Mo. Net Change: -73,428
# New Positions: 7
# Closed Positions: 2
# Increased Positions: 20
# Reduced Positions: 16
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.